This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


March 30–31, 2020
The Inn at Penn,
Philadelphia, PA

Stay on the Pulse of Federal and State Reporting Requirements, Policy Initiatives and Strategic Best Practices for Compliance

Join industry stakeholders to navigate evolving legislation, operationalize transparency requirements and enhance compliance and reporting practices. Assess how companies are planning internally for changes and gain a preview of what’s to come in 2020.

Take Advantage of our Advanced Pricing Discount...

Register By March 7, 2020 and Save $200!

What to Expect

High-Impact Topics Transforming Pricing Dynamics
  • Assess evolving drug pricing transparency legislation and litigation
  • Explore how the future of pricing transparency requirements will impact commercialization, reimbursement and drug pricing models
  • Deliver comprehensive legal interpretations of drug pricing transparency and reporting laws
  • Benchmark with industry peers on managing transparency requirements and reporting for compliance
Thought-Leaders Driving the Dialogue

Conference Chair
Sheea Sybblis, Senior Counsel, Boehringer Ingelheim

BIO Perspective:
John Murphy III, Deputy General Counsel, BIO

PhRMA View:
Joanne Chan, Assistant General Counsel, PhRMA

Price Increase Transparency:
Trevor Wear, Partner, Sidley Austin LLP

Enforcement Spotlight:
Steven Sharobem, Assistant U.S. Attorney, The United States Attorney’s Office for the District of Massachusetts

Viveca Parker, Assistant U.S. Attorney, The United States Attorney’s Office for the Eastern District of Pennsylvania

Roadmap for Compliance:
Jennifer Snow, Associate Director, State Transparency Reporting, Sandoz Inc.

Operational Readiness:
Amie Phillips Pablo, Director, Ethics and Compliance, Novo Nordisk

State Transparency Reporting Requirements Showcase
  • State of the Industry — Drug Pricing Transparency Landscape Address
  • Unpack Price Increase Transparency Requirements
  • Status Report on New Drug Pricing Reporting Requirements
  • Update on the Price Increase Advance Notice Requirements
  • Analyze Price Disclosure Requirements to Health Care Providers (HCPs)
  • Ask the Experts Round Up — What Keeps You Up at Night?
  • Keeping a Pulse on New Legislation and Current Industry Efforts

See Who Benefited from Attending in 2019


Connect with Key Decision-Makers at the Drug Pricing Transparency Congress

Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.

For more information about custom opportunities to reach a qualified audience, contact